Published Online:
May 11, 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objective of this review was to compare the effectiveness and safety of high dose (100 MU) and low dose (10 MU) interferon-alpha 2b for the treatment of carcinoma in situ of the bladder.